Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2012-004583-22-IT
EUCTR2012-004583-22-IT
Active, not recruiting
Not Applicable

Verification of the effectiveness of intravenous sildenafil compared to other pulmonary vasodilators used in the test vessel reactivity of pulmonary - Intravenous sildenafil in children

OSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA0 sitesOctober 25, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSubjects in children with congenital heart disease surgery or not, with echocardiographic signs of pulmonary hypertension followed at the Pediatric Cardiology Centre of the Mediterranean or reported by other centers I and Level II.MedDRA version: 14.1Level: SOCClassification code 10047065Term: Vascular disordersSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
DrugsREVATIO*EV 1FL 20ML 0,8MG/ML

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Subjects in children with congenital heart disease surgery or not, with echocardiographic signs of pulmonary hypertension followed at the Pediatric Cardiology Centre of the Mediterranean or reported by other centers I and Level II.
Sponsor
OSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2012
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
OSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA

Eligibility Criteria

Inclusion Criteria

  • •subjects in children with congenital heart disease surgery or not, with echocardiographic signs of pulmonary hypertension followed at the Pediatric Cardiology Centre of the Mediterranean or reported by other centers I and Level II.
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range: 13
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 2
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trial
IRCT20201004048922N1Tehran University of Medical Sciences75
Recruiting
Phase 3
Efficacy of intravenous administration of magnesium and pottasium solution in cardioversion of postoperative atrial fibrillatio
IRCT20180430039488N2Tehran University of Medical Sciences360
Recruiting
Phase 1
Placenta-derived mesenchymal stem cells and placenta-derived mesenchymal stem cells exosomes in the treatment of acute GvHDAcute GvHD.Graft-versus-host diseaseD89.81
IRCT20140818018842N40Tehran University of Medical Sciences60
Not yet recruiting
Phase 2
A study comparing two groups of patients undergoing bilateral total knee replacement one receiving only injection dexamethasone and other receiving injection levosulpiride with injection dexamethasone to assess the effect for post operative nausea and vomiting prophylaxis.Health Condition 1: M170- Bilateral primary osteoarthritis of kneeHealth Condition 2: O- Medical and Surgical
CTRI/2023/08/056491Dr Sunny Rupal
Completed
Not Applicable
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneratioage-related macular degeneration
JPRN-UMIN000005691Department of Ophthalmology, Shiga University of Medical Science40